Tivic Health raises ~$2.1M in public offering of 51.25M shares at $0.04/share

Valion Bio, Inc.

Offering of 51,250,000 shares priced at $0.040 per share, gross proceeds ~$2.1M.
Net proceeds ~$1.9M after placement agent fees and expenses; intended for working capital.
Maxim Group acted as placement agent, receiving 8% cash fee ($164,000) and 2,050,000 warrants.
Placement agent warrants exercisable at $0.048/share for 5 years, 6-month lockout from closing.
Officers and directors entered 30-day lock-up on company securities following closing.

item 1.01 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Valion Bio, Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2023-07-14).

Action: entry
Agreement: underwriting
Counterparty: Maxim Group LLC
Effective: 2023-07-14

Exact text from the filing

Maxim Group LLC agreed to act as the placement agent (the “Placement Agent”), on a “reasonable best efforts” basis, in connection with the Offering.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Valion Bio, Inc. entered into Purchase Agreement with the investors named on the signature pages thereto (the “Purchasers”) valued at approximately $2.1 million (effective 2023-07-14).

Action: entry
Agreement: equity purchase
Counterparty: the investors named on the signature pages thereto (the “Purchasers”)
Value: approximately $2.1 million
Effective: 2023-07-14

Exact text from the filing

On July 14, 2023, Tivic Health Systems, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with the investors named on the signature pages thereto (the “Purchasers”).

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Valion Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-033516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.